|
Lipids
Contributing journals to this collection:
Hypertension,
Circulation: Heart Failure,
Stroke,
Circulation Research,
Circulation: Arrhythmia and Electrophysiology,
Circulation: Cardiovascular Genetics,
Arteriosclerosis, Thrombosis, and Vascular Biology,
Circulation: Cardiovascular Outcomes and Quality,
Circulation,
Circulation: Cardiovascular Interventions,
and Circulation: Cardiovascular Imaging
Citations 1-10 of 870 total displayed.
- Editorial Commentaries
Does Junk Food Lead to Heart Failure?: Importance of Dietary Macronutrient Composition in Hypertension
- William C. Stanley, Keyur B. Shah, and M. Faadiel Essop
Hypertension 2009;54:1209-1210; published online before print as doi:10.1161/HYPERTENSIONAHA.109.128660
[Full text]
- Editorial Commentaries
Adenosine2A Receptors and Epoxyeicosatrienoic Acids: A Recipe for Salt and Blood Pressure Regulation
- John D. Imig
Hypertension 2009;54:1223-1225; published online before print as doi:10.1161/HYPERTENSIONAHA.109.129981
[Full text]
- Integrative Physiology/Experimental Medicine
Expression of Human ApoAII in Transgenic Rabbits Leads to Dyslipidemia: A New Model for Combined Hyperlipidemia
- Tomonari Koike, Shuji Kitajima, Ying Yu, Ying Li, Kazutoshi Nishijima, Enqi Liu, Huijun Sun, Ahmed Bilal Waqar, Nobumitsu Shibata, Tomoriho Inoue, Yao Wang, Bo Zhang, Junji Kobayashi, Masatoshi Morimoto, Keijiro Saku, Teruo Watanabe, and Jianglin Fan
Arterioscler Thromb Vasc Biol 2009;29:2047-2053; published online before print as doi:10.1161/ATVBAHA.109.190264
[Abstract]
[Full text]
- Heart Failure
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): A Retrospective Analysis
- John J.V. McMurray, John Kjekshus, Lars Gullestad, Peter Dunselman, Åke Hjalmarson, Hans Wedel, Magnus Lindberg, Finn Waagstein, Peer Grande, Jaromir Hradec, Gabriel Kamensky, Jerzy Korewicki, Timo Kuusi, François Mach, Naresh Ranjith, John Wikstrand for the CORONA Study Group
Circulation 2009;120:2188-2196; published online before print as doi:10.1161/CIRCULATIONAHA.109.849117
[Abstract]
[Full text]
- Cellular Biology
Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet
- Suzhao Li, Yu Sun, Chien-Ping Liang, Edward B. Thorp, Seongah Han, Andreas W. Jehle, Viswanathan Saraswathi, Brian Pridgen, Jenny E. Kanter, Rong Li, Carrie L. Welch, Alyssa H. Hasty, Karin E. Bornfeldt, Jan L. Breslow, Ira Tabas, and Alan R. Tall
Circ. Res. 2009;105:1072-1082; published online before print as doi:10.1161/CIRCRESAHA.109.199570
[Abstract]
[Full text]
- Original Article
"Vascular Age" is Advanced in Children with Atherosclerosis Promoting Risk Factors
- Joseph Le, Danna Zhang, Spencer Menees, Jie Chen, and Geetha Raghuveer
Circ Cardiovasc Imaging published November 17, 2009, doi:10.1161/CIRCIMAGING.109.880070
[Abstract]
- Articles
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). A Retrospective Analysis
- John J.V. McMurray, John Kjekshus, Lars Gullestad, Peter Dunselman, Åke Hjalmarson, Hans Wedel, Magnus Lindberg, Finn Waagstein, Peer Grande, Jaromir Hradec, Gabriel Kamensk
 , Jerzy Korewicki, Timo Kuusi, François Mach, Naresh Ranjith, John Wikstrand for the CORONA Study Group
Circulation published November 16, 2009, doi:10.1161/CIRCULATIONAHA.109.849117
[Abstract]
- Original Articles
Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors
- Gülmisal Güder, Stefan Frantz, Johann Bauersachs, Bruno Allolio, Christoph Wanner, Michael T. Koller, Georg Ertl, Christiane E. Angermann, and Stefan Störk
Circ Heart Fail 2009;2:563-571; published online before print as doi:10.1161/CIRCHEARTFAILURE.108.825059
[Abstract]
[Full text]
- Original Articles
Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)
- Paul M Ridker, Jean G. MacFadyen, Francisco A.H. Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn for the JUPITER Study Group
Circ Cardiovasc Qual Outcomes 2009;2:616-623; published online before print as doi:10.1161/CIRCOUTCOMES.109.848473
[Abstract]
[Full text]
- Original Articles
Atorvastatin Treatment Is Associated With Less Augmentation of the Carotid Pressure Waveform in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT)
- Charlotte Manisty, Jamil Mayet, Robyn J. Tapp, Peter S. Sever, Neil Poulter, Simon A. McG. Thom, Alun D. Hughes on behalf of the ASCOT Investigators
Hypertension 2009;54:1009-1013; published online before print as doi:10.1161/HYPERTENSIONAHA.109.130914
[Abstract]
[Full text]
|
|
